827 Shares in HCA Healthcare, Inc. (NYSE:HCA) Acquired by Mather Group LLC.

Mather Group LLC. purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 827 shares of the company’s stock, valued at approximately $224,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HCA. Kinetic Partners Management LP purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at $50,524,000. EP Wealth Advisors LLC increased its position in shares of HCA Healthcare by 501.8% during the 3rd quarter. EP Wealth Advisors LLC now owns 208,965 shares of the company’s stock valued at $51,401,000 after purchasing an additional 174,240 shares during the last quarter. Retirement Systems of Alabama boosted its stake in HCA Healthcare by 350.0% in the fourth quarter. Retirement Systems of Alabama now owns 204,812 shares of the company’s stock worth $55,439,000 after buying an additional 159,303 shares in the last quarter. Canada Pension Plan Investment Board raised its stake in shares of HCA Healthcare by 51.6% during the third quarter. Canada Pension Plan Investment Board now owns 355,730 shares of the company’s stock worth $87,502,000 after acquiring an additional 121,100 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp grew its holdings in shares of HCA Healthcare by 83.4% during the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 254,408 shares of the company’s stock valued at $62,579,000 after purchasing an additional 115,720 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of HCA opened at $307.68 on Friday. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The stock has a market cap of $81.38 billion, a PE ratio of 15.34, a price-to-earnings-growth ratio of 1.44 and a beta of 1.66. The firm’s 50-day simple moving average is $322.64 and its two-hundred day simple moving average is $297.17. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $335.83.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company’s revenue was up 11.2% on a year-over-year basis. During the same period last year, the company earned $4.93 earnings per share. Analysts anticipate that HCA Healthcare, Inc. will post 20.74 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

HCA Healthcare declared that its board has authorized a stock buyback plan on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 7.4% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board believes its shares are undervalued.

Analyst Ratings Changes

A number of research analysts have recently issued reports on HCA shares. Deutsche Bank Aktiengesellschaft raised their price objective on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research note on Friday, April 12th. Raymond James boosted their price objective on HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Royal Bank of Canada upped their price target on shares of HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Truist Financial upped their price objective on shares of HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Finally, TD Cowen reduced their price target on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a report on Tuesday. Four research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $316.59.

Insider Activity at HCA Healthcare

In other news, SVP Kathleen M. Whalen sold 4,262 shares of the firm’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $306.21, for a total transaction of $1,305,067.02. Following the sale, the senior vice president now owns 10,250 shares of the company’s stock, valued at approximately $3,138,652.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 4,262 shares of the business’s stock in a transaction on Friday, February 9th. The shares were sold at an average price of $306.21, for a total transaction of $1,305,067.02. Following the completion of the sale, the senior vice president now directly owns 10,250 shares in the company, valued at approximately $3,138,652.50. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Sammie S. Mosier sold 1,645 shares of the stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $312.00, for a total value of $513,240.00. Following the completion of the transaction, the senior vice president now directly owns 7,646 shares in the company, valued at approximately $2,385,552. The disclosure for this sale can be found here. Insiders have sold 7,127 shares of company stock valued at $2,218,364 over the last ninety days. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.